A Pharmacodynamic Study of Vismodegib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC) With Accessible Metastatic Lesions for Tumor Biopsy
Active, no longer recruiting
Phase of Trial: Phase 0
Latest Information Update: 03 Nov 2017
At a glance
- Drugs Vismodegib (Primary)
- Indications Prostate cancer
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 14 Oct 2016 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017.
- 14 Oct 2016 Status changed from recruiting to active, no longer recruiting.